[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[NH:11][C:10](=O)[C:9]3=[CH:13][C:14]([CH3:16])=[CH:15][N:8]3[CH2:7][C:6]=2[CH:17]=1.CN(C)C1C=CC=CC=1.P(Cl)(Cl)([Cl:29])=O>COC1C=CC=CC=1>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]=[C:10]([Cl:29])[C:9]3=[CH:13][C:14]([CH3:16])=[CH:15][N:8]3[CH2:7][C:6]=2[CH:17]=1To a suspension of 7-chloro-2-methyl-5,10-dihydro-11H-pyrrolo[2,1-c][1,4]benzodiazepin-11-one (40.6 g, 164.58 mmoles) in methoxybenzene (250 mL) at 70° C. add N,N-dimethylaniline (2.8 equiv; 58.59 mL, 460.8 mmoles) in one portion followed by phosphoryl chloride (2.3 equiv (molar); 35.18 mL, 378.52 mmoles) over 20 minutes, controlling the exotherm by addition. Heat the resultant dark solution at 90° C. for 1.5 h. Add additional phosphoryl chloride (0.33 equiv; 5.05 mL, 54.31 mmoles) and heat the mixture at 90° C. for a further 1 h to give complete conversion. Evaporate to near dryness and partition the residue between water (500 mL) and ethyl acetate (2×500 mL). Combine organic layers and wash with water (500 mL) then brine. Dry over Na2SO4, filter and evaporate onto silica. Pass through a silica gel pad with iso-hexane/ethyl acetate (gradient elution 5 to 25%). Combine product fractions and evaporate to a small amount of solvent. Add iso-hexane (150 mL) and collect the resulting yellow powder by filtration, to give 7,11-dichloro-2-methyl-5H-pyrrolo[2,1-c][1,4]benzodiazepine (34.0 g, 78% yield). MS (m/z): 265.1 (M+1).
読み込み中…
